RTW Venture Fund Limited specializes in identifying transformative assets with high growth potential across the life sciences, biopharmaceutical and medical technology sectors. The fund invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.

RTW Venture Fund Limited

RTW is a life sciences investment and innovation firm. Headquartered in New York with offices in London and Shanghai, we invest across the full lifecycle of companies including company creation, early stage venture capital, alternative financing, and public company investments.

Biomea Fusion

Milestone Pharmaceuticals

NeoGenomics

Orchard Therapeutics

Prometheus Biosciences

2seventy bio

Allakos

Athira Pharma

Avidity Biosciences

Solid Biosciences

Stoke Therapeutics

Third Harmonic Bio

UroGen Pharma

C4 Therapeutics

CinCor Pharma

GH Research

immatics biotechnologies

Immunic Therapeutics

Rocket Pharmaceuticals

Roivant Sciences

Ventyx Biosciences

Science 37

Pulmonx

REGENXBIO

Renovacor

Immunocore

RTW Investments, LP

On National Intern Day we want to recognize our 2023 summer intern class.

Our exceptional group of interns has been actively engaged in various summer projects, ranging from research and development tracking to fundraising coordination, data organization, and therapeutic asset research. We extend our gratitude to Stela Sota, Halle Fiedler, Yifei Zhang, Sophie Takmopoulos, Karan Naik, Vincent Masto, and Yen-Der Li, MD, PhD for their dedicated efforts and hard work!

#Interns #RTWInterns #NationalInternday #InternAppreciation

This morning we announced Igor Splawski has joined RTW’s Yarrow Biotechnology as Chief Scientific Officer. Thanks to Lei Lei Wu for the Endpoints News Peer Review piece highlighting Igor’s unique style and deep expertise. Welcome to the team, Igor!

https://lnkd.in/gZPCXztt

Our managing director and CIO, Roderick Wong recently sat down with Daniel Coatsworth for AJ Bell’s Money and Markets podcast. The two discussed biotech M&A trends, our approach to investing in therapies targeting rare diseases, and some of the companies Rod’s excited about right now. The full episode featuring insights on the mortgage market and higher interest rate impacts on other sectors can be found at the below link. Rod’s portion starts just before the 27-minute mark. 

#biotech #investing #lifesciences 

https://lnkd.in/efJMxFJN

Investing in life sciences means not only believing in the power of science but understanding it. Our team of scientists, investors, and entrepreneurs digs deep to identify the most promising innovations and foster them to ensure they have the best chance of creating real life-changing impact on patients. Hear more about how science shapes our approach to investing. Featuring voiceover by our very own Hanah Gershkowitz.

Our purpose goes beyond short-term financial gains. It’s about powering the next innovations that will transform lives. Hear more about why we do what we do through the voice of our own Paula Boone.

Our culture at RTW is shaped by our people, our values, and the passion we share for powering innovative science to impact millions of lives. Hear more about what it’s like to work at RTW as told by our people.

#lifesciences #culture #investing #biotech

#ICYMI: Roderick Wong recently sat down with Capital Allocators’ Ted Seides to share his views on life sciences investing, the growth and evolution of RTW over the years, and some of the lessons he’s learned along the way. 
https://lnkd.in/eJjekwvm

#lifesciences #biotech #investing

Congrats to the ACELYRIN, INC. team on its Nasdaq debut. We're proud to continue to support the company in its mission to develop treatments for patients with inflammatory conditions.

	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
account payables			145.93K -	492.01K 237.15%	5.56M 1,030.38%
accumulated other comprehensive income loss
cash and cash equivalents	31.32K -	10.73M 34,159.21%	4.55M 57.57%	6.48M 42.40%	6.97M 7.44%	2.72M 60.93%
cash and short term investments	31.32K -	10.73M 34,159.21%	4.55M 57.57%	6.48M 42.40%	6.97M 7.44%	2.72M 60.93%
common stock
deferred revenue
deferred revenue non current
deferrred tax liabilities non current
goodwill
goodwill and intangible assets
intangible assets
inventory
long term debt		202.93K -
long term investments	65.72M -	171.98M 161.68%	395.50M 129.97%	420.16M 6.23%	371.59M 11.56%	383.08M 3.09%
net debt	-31.32K -	-10.53M 33,511.36%	-4.55M 56.75%	-6.48M 42.40%	-6.97M 7.44%	-2.72M 60.93%
net receivables		33.08M -	20.72M 37.38%	12.52M 39.55%	22.64M 80.73%	34.09M 50.62%
other assets	2.86K -	5.81K 103.15%	124.58K 2,044.89%	191.56K 53.77%	22.54M 11,666.87%	26.34M 16.87%
other current assets
other current liabilities			-145.93K -	-492.01K 237.15%	-5.56M 1,030.38%
other liabilities	32.24K -				42.49M -
other non current assets	-65.72M -	-171.98M 161.68%	-395.50M 129.97%	-420.16M 6.23%	-371.59M 11.56%	-383.08M 3.09%
other non current liabilities		-202.93K -			5.56M -
othertotal stockholders equity	65.72M -
preferred stock
property plant equipment net
retained earnings
short term debt
short term investments
tax assets
tax payables
total assets	65.76M -	215.80M 228.18%	420.90M 95.04%	439.36M 4.39%	401.54M 8.61%	446.23M 11.13%
total current assets	31.32K -	43.82M 139,776.99%	25.27M 42.32%	19.01M 24.78%	7.41M 61.04%	36.82M 397.10%
total current liabilities			145.93K -	492.01K 237.15%	5.56M 1,030.38%
total debt		202.93K -
total investments	65.72M -	171.98M 161.68%	395.50M 129.97%	420.16M 6.23%	371.59M 11.56%	383.08M 3.09%
total liabilities	32.24K -	202.93K 529.50%	145.93K 28.09%	492.01K 237.15%	53.62M 10,797.49%
total liabilities and stockholders equity	65.76M -	215.80M 228.18%	420.90M 95.04%	439.36M 4.39%	401.54M 8.61%	446.23M 11.13%
total non current assets	65.72M -	171.98M 161.68%	395.50M 129.97%	420.16M 6.23%	371.59M 11.56%	383.08M 3.09%
total non current liabilities		202.93K -			5.56M -
total stockholders equity	65.72M -	214.39M 226.20%	412.61M 92.46%	387.36M 6.12%	347.92M 10.18%	429.02M 23.31%

COM:RTWFUNDS

RTW Funds

Last Close

1.21

31/03 15:35

Market Cap

502.74M

Beta: -

Volume Today

6.03K

Avg: -

Preview